BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 15331612)

  • 1. Activator protein 2alpha associates with adenomatous polyposis coli/beta-catenin and Inhibits beta-catenin/T-cell factor transcriptional activity in colorectal cancer cells.
    Li Q; Dashwood RH
    J Biol Chem; 2004 Oct; 279(44):45669-75. PubMed ID: 15331612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of integrin linked kinase (ILK) suppresses beta-catenin-Lef/Tcf-dependent transcription and expression of the E-cadherin repressor, snail, in APC-/- human colon carcinoma cells.
    Tan C; Costello P; Sanghera J; Dominguez D; Baulida J; de Herreros AG; Dedhar S
    Oncogene; 2001 Jan; 20(1):133-40. PubMed ID: 11244511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Yin-Yang of TCF/beta-catenin signaling.
    Barker N; Morin PJ; Clevers H
    Adv Cancer Res; 2000; 77():1-24. PubMed ID: 10549354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activator protein 2alpha suppresses intestinal tumorigenesis in the Apc(min) mouse.
    Li Q; Löhr CV; Dashwood RH
    Cancer Lett; 2009 Sep; 283(1):36-42. PubMed ID: 19376641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the beta-catenin/T cell factor signaling pathway in 36 gastrointestinal and liver cancer cells.
    Ikenoue T; Ijichi H; Kato N; Kanai F; Masaki T; Rengifo W; Okamoto M; Matsumura M; Kawabe T; Shiratori Y; Omata M
    Jpn J Cancer Res; 2002 Nov; 93(11):1213-20. PubMed ID: 12460462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta- and gamma-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer.
    Caca K; Kolligs FT; Ji X; Hayes M; Qian J; Yahanda A; Rimm DL; Costa J; Fearon ER
    Cell Growth Differ; 1999 Jun; 10(6):369-76. PubMed ID: 10392898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of a BCL9-related beta-catenin-binding protein, B9L, in tumorigenesis induced by aberrant activation of Wnt signaling.
    Adachi S; Jigami T; Yasui T; Nakano T; Ohwada S; Omori Y; Sugano S; Ohkawara B; Shibuya H; Nakamura T; Akiyama T
    Cancer Res; 2004 Dec; 64(23):8496-501. PubMed ID: 15574752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC.
    Morin PJ; Sparks AB; Korinek V; Barker N; Clevers H; Vogelstein B; Kinzler KW
    Science; 1997 Mar; 275(5307):1787-90. PubMed ID: 9065402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of cyclooxygenase-2 expression by the Wnt and ras pathways.
    Araki Y; Okamura S; Hussain SP; Nagashima M; He P; Shiseki M; Miura K; Harris CC
    Cancer Res; 2003 Feb; 63(3):728-34. PubMed ID: 12566320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A yeast model system for functional analysis of beta-catenin signaling.
    Lee MS; D'Amour KA; Papkoff J
    J Cell Biol; 2002 Sep; 158(6):1067-78. PubMed ID: 12235124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. gamma-catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of beta-catenin.
    Kolligs FT; Kolligs B; Hajra KM; Hu G; Tani M; Cho KR; Fearon ER
    Genes Dev; 2000 Jun; 14(11):1319-31. PubMed ID: 10837025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APC, beta-Catenin and hTCF-4; an unholy trinity in the genesis of colorectal cancer.
    Bright-Thomas RM; Hargest R
    Eur J Surg Oncol; 2003 Mar; 29(2):107-17. PubMed ID: 12633551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reconstructed beta-catenin/TCF4 signaling in yeast applicable to functional evaluation of APC mutations.
    Yamada H; Furuuchi K; Aoyama T; Kataoka A; Hamada J; Tada M; Okushiba S; Kondo S; Moriuchi T; Katoh H
    Am J Pathol; 2003 Dec; 163(6):2201-9. PubMed ID: 14633595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut-enriched Krüppel-like factor regulates colonic cell growth through APC/beta-catenin pathway.
    Stone CD; Chen ZY; Tseng CC
    FEBS Lett; 2002 Oct; 530(1-3):147-52. PubMed ID: 12387883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selection of multipotent stem cells during morphogenesis of small intestinal crypts of Lieberkuhn is perturbed by stimulation of Lef-1/beta-catenin signaling.
    Wong MH; Huelsken J; Birchmeier W; Gordon JI
    J Biol Chem; 2002 May; 277(18):15843-50. PubMed ID: 11854293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signaling through beta-catenin and Lef/Tcf.
    Novak A; Dedhar S
    Cell Mol Life Sci; 1999 Oct; 56(5-6):523-37. PubMed ID: 11212302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastrin is a target of the beta-catenin/TCF-4 growth-signaling pathway in a model of intestinal polyposis.
    Koh TJ; Bulitta CJ; Fleming JV; Dockray GJ; Varro A; Wang TC
    J Clin Invest; 2000 Aug; 106(4):533-9. PubMed ID: 10953028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma.
    Korinek V; Barker N; Morin PJ; van Wichen D; de Weger R; Kinzler KW; Vogelstein B; Clevers H
    Science; 1997 Mar; 275(5307):1784-7. PubMed ID: 9065401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of c-MYC as a target of the APC pathway.
    He TC; Sparks AB; Rago C; Hermeking H; Zawel L; da Costa LT; Morin PJ; Vogelstein B; Kinzler KW
    Science; 1998 Sep; 281(5382):1509-12. PubMed ID: 9727977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of Icat induces G(2) arrest and cell death in tumor cell mutants for adenomatous polyposis coli, beta-catenin, or Axin.
    Sekiya T; Nakamura T; Kazuki Y; Oshimura M; Kohu K; Tago K; Ohwada S; Akiyama T
    Cancer Res; 2002 Jun; 62(11):3322-6. PubMed ID: 12036951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.